31 results on '"Ramnath N"'
Search Results
2. P2.09-15 Real World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer
3. Symptomatic Pneumonitis Rates Among Patients with Stage III Non-Small Cell Lung Cancer Receiving Adjuvant Durvalumab
4. Efficiency Effectiveness Gap of Durvalumab in Locally Advanced Non-Small Cell Lung Cancer
5. Real-Time Surveillance of New Anticancer Therapies in the National Veterans Affairs System
6. P57.03 Cellular Engagement and Interaction in the Tumor Microenvironment (TME) Predicts Response to ICI in Metastatic NSCLC
7. P21.09 Does Duration of Maintenance Durvalumab Matter? Relationship between Length of Durvalumab Therapy and PFS.
8. P78.05 Patterns of irAE During First Line Pembrolizumab for NSCLC: Incidence, Risk Factors, and Impact on Clinical Outcome
9. P1.01-71 Bone Metastases and Skeletal-Related Events in Patients with Metastatic NSCLC Treated with ICIs: A Multi-Institutional Study
10. Predictors of Post-Treatment Hospitalization in Lung Cancer Patients Treated with Stereotactic Body Radiotherapy (SBRT) for Centrally Located Tumors
11. FDG PET-CT Quantitative Features Predict Immune Checkpoint Blockade Efficacy
12. Predictors of Long-Term Survival Among Locally Advanced Non–small Cell Lung Cancer Patients Undergoing Definitive Radiation Therapy
13. Clinical Predictors of Durable Clinical Benefit of Pembrolizumab Therapy in Veterans With Metastatic Non–Small Cell Lung Cancer
14. A Phase II Trial of Midtreatment PET-CT Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Inoperable/Unresectable Non-Small Cell Lung Cancer (NSCLC)
15. Concurrent Carboplatin, Paclitaxel, and Selenomethionine in Combination With Radiation for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase 2 Multicenter Trial
16. A Phase 2 Trial of Midtreatment FDG-PET Adaptive, Individualized Radiation Therapy Plus Concurrent Chemotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)
17. Personalized High Dose Radiation (>70 Gy) Is Significantly Associated with Better Local Regional Control and Overall Survival in Non-small Cell Lung Cancer Treated with Concurrent Chemoradiation
18. Re-irradiation May be a Viable Option for Patients with Local Recurrence after a Definitive Course of Radiation Therapy in Non-small Cell Lung Cancer
19. Can We Deliver High Dose Radiation in 6 Weeks with Concurrent Chemotherapy in Stage III Non-small Cell Lung Cancer?
20. Concurrent Chemoradiotherapy Increases the Risk of Radiation-Induced Pericardial Effusion in Patients with Locally Advanced Non-small Cell Lung Cancer
21. The Additional Value of V/Q SPECT over Q SPECT Alone for Pulmonary Function Mapping before, during and after Radiotherapy in Patients with Non–small Cell Lung Cancer
22. 381 POSTER HSP27 as a novel target in Non-small cell lung cancer with particular implications for migration and metastasis
23. 2458
24. PD-100 Neoadjuvant chemotherapy with gemcitabine and vinorelbine inresectable non-small-cell lung cancer (NSCLC)
25. O-052 Hormone replacement therapy and the risk of lung cancer in post-menopausal women
26. Clinicopathological correlation of expression of MCM2 in patients with non-small cell lung cancer (NSCLC)
27. 578 Activity of 9-cis-retinoic acid (9cRA), TTNPB and LG100153 against small cell lung cancer (SCLC) cells in vitro
28. Rates of oxidation of thioketones by singlet oxygen
29. The problem of triplet self-quenching in thioketone photochemistry
30. Efficiency of singlet oxygen production by thiocarbonyls
31. Micellar structure and micellar control of photochemical reactions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.